Plaquenil contains hydroxychloroquine sulfate, an aminoquinoline antimalarial and disease-modifying antirheumatic drug (DMARD) for malaria and certain autoimmune diseases. It acts in acidic…
Plaquenil contains hydroxychloroquine sulfate, an aminoquinoline antimalarial and disease-modifying antirheumatic drug (DMARD) for malaria and certain autoimmune diseases. It acts in acidic intracellular compartments and parasites, disrupting malaria parasite haemoglobin processing and reducing inflammatory immune activity.
Plaquenil contains hydroxychloroquine sulfate, an aminoquinoline antimalarial and disease-modifying antirheumatic drug (DMARD). The product form is an oral tablet. Hydroxychloroquine is listed under ATC code P01BA02.
The medicine acts inside cells and parasites. It accumulates in acidic intracellular compartments called lysosomes and interferes with processes that depend on acidity. In malaria parasites, this disrupts haemoglobin processing. In autoimmune disease, hydroxychloroquine reduces antigen processing and several inflammatory signalling pathways, which can calm immune activity over time.
Hydroxychloroquine is not a steroid, sedative, or painkiller. Its benefit in rheumatoid arthritis and lupus develops gradually because it changes inflammatory activity rather than producing immediate symptom relief.
Plaquenil is indicated for malaria prophylaxis and treatment, systemic lupus erythematosus, discoid lupus erythematosus, and rheumatoid arthritis. Treatment should be selected and monitored by a healthcare professional.
Plaquenil contains hydroxychloroquine sulfate as its active ingredient. It is an aminoquinoline antimalarial and disease-modifying antirheumatic drug supplied as an oral tablet. The product is listed under ATC code P01BA02.
Hydroxychloroquine works against malaria parasites and also modifies immune activity in autoimmune disease. Its effects in lupus and rheumatoid arthritis develop over time rather than providing immediate symptom relief.
Plaquenil is an oral, single-active-ingredient prescription treatment with both antimalarial and disease-modifying antirheumatic uses. Its mechanism differs from treatments that act mainly through immediate symptom relief, and the appropriate choice depends on the condition being treated and medical assessment.
Plaquenil may cause digestive discomfort or other unwanted effects, and an allergic or skin reaction is possible. People who are pregnant, have a known allergy, or take interacting medicines should discuss its use with a doctor or pharmacist. Seek medical advice if symptoms are severe or persistent.
A doctor would generally view Plaquenil as a prescription treatment that requires a clear diagnosis and realistic expectations. Consistent use as agreed with the prescriber is important, while new, worsening, or concerning symptoms should be discussed with a physician.
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.
Based on 3 reviews
I have used Plaquenil consistently for about three months for lupus. My joint discomfort has eased gradually, although I noticed mild stomach upset during the first week.
Coventry 3 months 6 Oct 2026After several weeks of treatment for rheumatoid arthritis, I feel somewhat better in the mornings. The improvement is modest, and I contacted my doctor about occasional digestive discomfort.
Leicester 7 weeks 20 Oct 2026I stopped Plaquenil after a short period because I developed a skin reaction and did not want to continue without medical advice. My doctor is reviewing the treatment with me.
Luton 2 weeks 1 Nov 2026
